Copyright Notice
Attribution Statement: LactMed is a registered trademark of the U.S. Department of Health and Human Services.
Bookshelf ID: NBK501006PMID: 30000065
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006-.
CASRN: 83915-83-7
Drug Levels and Effects
Summary of Use during Lactation
Because no information is available on the use of lisinopril during breastfeeding, an alternate drug may be preferred, especially while nursing a newborn or preterm infant.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
Substance Identification
Substance Name
Lisinopril
CAS Registry Number
83915-83-7
Drug Class
- Breast Feeding
- Antihypertensive Agents
- Angiotensin-Converting Enzyme Inhibitors
- ACE Inhibitors
- ACEIs
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- User and Medical Advice Disclaimer
- LactMed App
- Drugs and Lactation Database (LactMed) - Record Format
- LactMed - Database Creation and Peer Review Process
- Fact Sheet. Drugs and Lactation Database (LactMed)
- Drugs and Lactation Database (LactMed) - Glossary
- LactMed Selected References
- Drugs and Lactation Database (LactMed) - About Dietary Supplements
- Breastfeeding Links
- PubChem SubstanceRelated PubChem Substances
- Synthesis of N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (lisinopril).[J Pharm Sci. 1985]Synthesis of N2-[(S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline (lisinopril).Wu MT, Douglas AW, Ondeyka DL, Payne LG, Ikeler TJ, Joshua H, Patchett AA. J Pharm Sci. 1985 Mar; 74(3):352-4.
- Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.[J Biol Chem. 1985]Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.Bull HG, Thornberry NA, Cordes MH, Patchett AA, Cordes EH. J Biol Chem. 1985 Mar 10; 260(5):2952-62.
- Review Ramipril.[Drugs and Lactation Database (...]Review Ramipril.. Drugs and Lactation Database (LactMed®). 2006
- Radioimmunoassay for the quantitation of lisinopril and enalaprilat.[J Pharm Sci. 1986]Radioimmunoassay for the quantitation of lisinopril and enalaprilat.Worland PJ, Jarrott B. J Pharm Sci. 1986 May; 75(5):512-6.
- Review Trandolapril.[Drugs and Lactation Database (...]Review Trandolapril.. Drugs and Lactation Database (LactMed®). 2006
- Lisinopril - Drugs and Lactation Database (LactMed®)Lisinopril - Drugs and Lactation Database (LactMed®)
Your browsing activity is empty.
Activity recording is turned off.
See more...